Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (11)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Larsson, E.
Right arrow Articles by Saxne, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Larsson, E.
Right arrow Articles by Saxne, T.
Related Collections
Right arrow Experimental Arthritis
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Rheumatology 2002; 41: 996-1000
© 2002 British Society for Rheumatology


Original papers

Serum concentrations of cartilage oligomeric matrix protein, fibrinogen and hyaluronan distinguish inflammation and cartilage destruction in experimental arthritis in rats

E. Larsson, H. Erlandsson Harris, J. C. Lorentzen, A. Larsson1, B. Månsson2, L. Klareskog and T. Saxne2

Department of Medicine, Rheumatology Unit, Karolinska Hospital, Stockholm,
1 Department of Clinical Chemistry, University Hospital Uppsala and
2 Department of Rheumatology and Department of Cell and Molecular Biology, Lund University, Sweden

Objectives. We investigated if changes in serum/plasma fibrinogen (FIB), hyaluronan (HA) and cartilage oligomeric matrix protein (COMP) levels can be used to differentiate between inflammation and cartilage involvement during arthritis.

Methods. Collagen-induced arthritis (CIA), oil-induced arthritis (OIA) and for comparison, experimental autoimmune encephalitis (EAE) induced in DA rats were investigated.

Results. Elevations of FIB concentrations were apparent at days 4–7 post-immunization in both arthritis models reaching a maximum on day 20–21, i.e. before peak arthritis. Elevations of HA in both models were seen shortly before macroscopically apparent arthritis, and peaked at or just before maximal arthritis, i.e. later in CIA than in OIA. COMP levels increased only after onset of arthritis and peaked late in disease (days 34–37), being significantly higher in the more destructive CIA compared with the less destructive OIA. During EAE flares, only FIB levels increased.

Conclusions. FIB is a general inflammation marker, HA appears to be a marker for synovitis and changes in COMP levels appear to reflect the cartilage destruction process.

KEY WORDS: Collagen-induced arthritis, Oil-induced arthritis, Experimental autoimmune encephalomyelitis, Cartilage oligomeric matrix protein, Fibrinogen, Hyaluronan.

Correspondence to: E. Larsson, Rheumatology Unit, Department of Medicine, Karolinska Hospital, S-171 76 Stockholm, Sweden.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Rheumatology (Oxford)Home page
I. Bileviciute-Ljungar, T. Saxne, and M. Spetea
Anti-inflammatory effects of contralateral administration of the {kappa}-opioid agonist U-50,488H in rats with unilaterally induced adjuvant arthritis
Rheumatology, March 1, 2006; 45(3): 295 - 302.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
E. Larsson, H. Erlandsson Harris, A. Larsson, B. Mansson, T. Saxne, and L. Klareskog
Corticosteroid treatment of experimental arthritis retards cartilage destruction as determined by histology and serum COMP
Rheumatology, April 1, 2004; 43(4): 428 - 434.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.